Stroke Prevention: Past, Present, and Future

  • John W. Norris
  • Vladimir C. Hachinski


Strokes of all types have yet to yield to any past or current medical intervention. Preventing stroke is much easier than treating it, as in other forms of vascular disorders, such as ischemic heart disease. In spite of dramatic claims for the prevention of coronary heart disease in both lay and medical media, a review of scientific evidence suggests that they are premature.


Stroke Prevention Carotid Endarterectomy Recurrent Stroke Minor Stroke Asymptomatic Carotid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA. 1982;248:1465–1477.Google Scholar
  2. 2.
    McCormick J, Skrabanek P: Coronary heart disease is not preventable by population intervention. Lancet. 1988;2:839–841.PubMedGoogle Scholar
  3. 3.
    Iso H, Jacobs DR, Wentworth D, et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 1989;320:904–910.PubMedGoogle Scholar
  4. 4.
    Sherwin RW, Wentworth DN, Cutler JA, et al. Serum cholesterol levels and cancer mortality in 361,622 men screened for the Multiple Risk Factor Intervention Trial. JAMA. 1987;257:943–948.PubMedGoogle Scholar
  5. 5.
    Virchow R: Über die akut Entzundung der Arterien. Virchow’s Arch A. 1847;1:272–378.Google Scholar
  6. 6.
    Fisher CM, Adams RD: Observations on brain embolism with special reference to hemorrhagic infarction. In: Furlan Anthony J, ed. The Heart and Stroke. New York, NY: Springer-Verlag; 1987:1 pp 17–36.Google Scholar
  7. 7.
    Chiari H: Uber das Verhalten des Tielungswinkels der Carotis communis bei der Endarteritis chronica deformans. Verhandl d deutsch path Gesellsch. 1905;9:326–330.Google Scholar
  8. 8.
    Fisher CM: Occlusion of the internal carotid artery. Arch Neurol Psychiat. 1951;65:346–377.Google Scholar
  9. 9.
    Fisher CM, Cameron DG: Concerning cerebral vasospasm. Neurology. 1953;3:468–473.PubMedGoogle Scholar
  10. 10.
    Marshall J: The natural history of transient ischaemic cerebro-vascular attacks. Q J Med. 1964;33: 309–324.PubMedGoogle Scholar
  11. 11.
    Whisnant JP, Matsumoto N, Elveback LR: Transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973;48:194–198.PubMedGoogle Scholar
  12. 12.
    Miller VT: Lacunar stroke: a reassessment. Arch Neurol. 1983;40:129–134.PubMedGoogle Scholar
  13. 13.
    Thompson JE, Patman RD, Talkington CM: Asymptomatic carotid bruit. Ann Surg. 1978;3: 308–316.Google Scholar
  14. 14.
    Heyman A, Wilkinson W, Heyden S, et al. Risk of stroke in asymptomatic persons with cervical arterial bruits. N Engl J Med. 1980;302:838–841.PubMedGoogle Scholar
  15. 15.
    Dyken ML: Carotid endarterectomy studies: a glimmering of science. Stroke. 1986;17:355–358.PubMedGoogle Scholar
  16. 16.
    Brown M, Glassenberg M. Mortality factors in patients with acute stroke. JAMA. 1973;224:1493–1495.PubMedGoogle Scholar
  17. 17.
    Whisnant JP, Matsumoto N, Elveback LR. The effect of anticoagulant therapy in the prognosis of patients with transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973;48:844–848.PubMedGoogle Scholar
  18. 18.
    Norris JW, Dalton JG. Outcome of patients with asymptomatic carotid bruits. In: Reivich M, Hurtig HI, eds. Cerebrovascular Diseases. New York, NY: Raven Press; 1983:1 pp 63–71.Google Scholar
  19. 19.
    Charcot JM, Bouchard C. Nouvelles recherches sur la pathogenie de l’hemorrhagie cerebrale. Arch Physiol Norm Path. 1868;1:110–127;643–645; 725–734.Google Scholar
  20. 20.
    Cole FM, Yates PO. The occurrence and significance of intracerebral microaneurysms. J Path Bad. 1967;93:393–411.Google Scholar
  21. 21.
    Whisnant, JP. The role of the neurologist in the decline of stroke. Ann Neurol. 1983;14:1–7.PubMedGoogle Scholar
  22. 22.
    Bonita R, Beaglehole R. Increased treatment of hypertensiorfdoes not explain the decline in stroke mortality in the United States 1970–1980. Hypertension. 1989; 13 (suppl l):I69-I73.Google Scholar
  23. 23.
    Wolf PA, dAgostino RB, Kannel WB, et al. Cigarette smoking as a risk factor for stroke. JAMA. 1988;259:1025–1029.PubMedGoogle Scholar
  24. 24.
    Barnett HJM, Boughner DR, Taylor DW, et al. Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med. 1980;302: 139–144.PubMedGoogle Scholar
  25. 25.
    Baker RN, Broward JA, Fang HC, et al. Angicoagulant therapy of cerebral infarction: report of a national cooperative study. In: Millikan CH, ed. Cerebrovascular Disease, Proceedings of Association for Research in Nervous and Mental Disease. Baltimore, MD: William and Wilkins; 1966:1 pp 287–302.Google Scholar
  26. 26.
    Whisnant JP, Cartlidge NEF, Elveback LR. Carotid and vertebral-basilar transient ischemic attacks: effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence—a population study. Ann Neurol 1978; 3:107–115.PubMedGoogle Scholar
  27. 27.
    Jonas S. Anticoagulant therapy in cerebrovascular disease: review and meta-analysis. Stroke. 1988; 19:1043–1048.PubMedGoogle Scholar
  28. 28.
    Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J. 1988;296:313–316.Google Scholar
  29. 29.
    Hass W, Easton JD, Adams HP Jr, Pryse-Phillips W, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989; 321:501–507.PubMedGoogle Scholar
  30. 30.
    Gent M, Easton JD, Hachinski VC, et al. The Canadian-American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989;1:1215–1220.PubMedGoogle Scholar
  31. 31.
    Moniz E. L’encephalographie arterielle, son importance dans la localisation des tumeurs cerebrales. Rev Neurol 1927;2:72–90.Google Scholar
  32. 32.
    Eastcott HHG, Pickering GW, Rob CG. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet. 1954; 2:994–996.Google Scholar
  33. 33.
    Barnett HJM, Plum F, Walton JN. Carotid endarter-ectomy—an expression of concern. Stroke. 1984; 15: 941–943.PubMedGoogle Scholar
  34. 34.
    The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomised trial. N Engl J Med. 1985;313:1191–1200.Google Scholar
  35. 35.
    Pearce JMS, Gubbay SS, Walton JN. Long-term anticoagulant therapy in transient cerebral ischemic attacks. Lancet. 1965;1:6–9.PubMedGoogle Scholar
  36. 36.
    The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl Med. 1978;299:53–59.Google Scholar
  37. 37.
    Antiplatelet Trialists’ Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Brit Med J. 1988;296:320–331.Google Scholar
  38. 38.
    Taylor DW, Sackett DL, Haynes RB. Sample size for randomized trials in stroke prevention. How many patients do we need? Stroke. 1984; 15:968–971.PubMedGoogle Scholar
  39. 39.
    Robins M, Baum HM. National survey of stroke. Incidence. Stroke. 1981;12(suppl 2):1–45, 1–57.Google Scholar
  40. 40.
    Welin L, Svardsudd K, Wilhelmsen L, et al. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med. 1987;317:521–526.PubMedGoogle Scholar
  41. 41.
    Inzitari D, Hachinski VC, Taylor DW, et al. Racial differences in the anterior circulation of cerebrovascular disease: how much can be explained by risk factors? Arch Neurol. 1990;47:1080–1084.PubMedGoogle Scholar
  42. 42.
    Wolf PA, Kannel WB, Verter J. Current status of risk factors for stroke. Neurol Clin North Am. 1983;1:317.Google Scholar
  43. 43.
    Veterans Administration Cooperative Study in Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1928–1034.Google Scholar
  44. 44.
    Veterans Administration Cooperative Study in Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 90–144 mm Hg. JAMA. 1970;213:1143–1152.Google Scholar
  45. 45.
    Veterans Administration Cooperative Study in Antihypertensive Agents. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure and prior cardiovascular disease; further analysis of side effects. Circulation. 1972; 45:991–1004.Google Scholar
  46. 46.
    Barnett HJM. Heart in ischemic stroke—a changing emphasis. Neurol Clin North Am. 1983;1:291 – 315.Google Scholar
  47. 47.
    Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. Br Med J. 1989;298:789–794.Google Scholar
  48. 48.
    Kannel WB, Wolfe PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. JAMA. 1987;258:1183–1186.PubMedGoogle Scholar
  49. 49.
    Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311: 501–511.PubMedGoogle Scholar
  50. 50.
    Mershey C, Wohl H. Changes in blood coagulation and fibrinolysis in rats fed atherogenic diets. Thromb Diathes Haemorrh. 1964; 10:295.Google Scholar
  51. 51.
    Lowe GDO, Drummond MM, Third JLH, et al. Increased plasma fibrinogen and platelet aggregates in type II hyperlipoproteinemia. Thromb Haemost. 1979;42:1503–1507.Google Scholar
  52. 52.
    Plum F. What causes infarction in ischemic brain? The Robert Wartenberg Lecture. Neurology. 1983; 33:222–233.PubMedGoogle Scholar
  53. 53.
    Kannel WB, Gordon T, Wolf PA. Hemoglobin and the risk of cerebral infarction: the Framingham Study. Stroke. 1972;3:409.PubMedGoogle Scholar
  54. 54.
    Herman B, Leyten ACM, van Lujik CWGM. An evaluation of risk factors for stroke in a Dutch community. Stroke. 1982;13:334–339.PubMedGoogle Scholar
  55. 55.
    Murai A, Tanaka T, Miyahara T, et al. Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke. 1981;12:167–172.PubMedGoogle Scholar
  56. 56.
    Mendez I, Hachinski VC, Wolfe BM. Serum lipids after stroke. Neurology. 1987;37:501–511.Google Scholar
  57. 57.
    Khaw K, Barrett-Connor E. Dietary potassium and stroke-associated mortality: a 12-year prospective population study. N Engl J Med. 1987;316:235–240.PubMedGoogle Scholar
  58. 58.
    Wolf PA, et al. Epidemiologic assessment of chronic atrial fibrillation of risk of stroke: the Framingham Study. Neurology. 1978;28:973–977.PubMedGoogle Scholar
  59. 59.
    Hachinski VC, Norris JW The acute stroke. In: Plum F, ed. Contemporary Neurology Series, vol 27. Philadelphia, PA: FA Davis; 1985. pp. 141–163.Google Scholar
  60. 60.
    Statistics Canada. Statistics Canada: Causes of Death1978. Ottawa: Queen’s Printer; 1980.Google Scholar
  61. 61.
    Jones HR, Jr, et al. Cerebral emboli of paradoxical origin. Ann Neurol. 1983; 13:314.PubMedGoogle Scholar
  62. 62.
    Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol. 1988;23:380–384.PubMedGoogle Scholar
  63. 63.
    Briley DP, Coull BM, Goodnight SH Jr. Neurological disease associated with antiphospholipid antibodies. Ann Neurol. 1989;25:221–227.PubMedGoogle Scholar
  64. 64.
    Bell DA (personal communication).Google Scholar
  65. 65.
    Trimble M, Bell D, Brien W, et al. The antiphos-pholipid syndrome: prevalence among patients with stroke and transient ischemic attacks. Am J Med. 1990;88:593–597.PubMedGoogle Scholar
  66. 66.
    Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women; associated risk factors. JAMA. 1975;231:718–722.Google Scholar
  67. 67.
    Royal College of General Practitioners. Incidence of arterial disease among oral contraceptive users. J Roy Coll Gen Pract. 1983;33:75–82.Google Scholar
  68. 68.
    Vessey MP, Villard-Mackintosh L, McPherson K, et al. Mortality among oral contraceptive users: 20-year follow up of women in a cohort study. Br MedJ. 1989;299:1487–1491.Google Scholar
  69. 69.
    Dyken ML, Wolf PA, Barnett HJM, et al. Risk factors in stroke. Stroke. 1984;15:1105–1111.Google Scholar
  70. 70.
    Powars D, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med. 1978;64:461–471.Google Scholar
  71. 71.
    Boers GHJ, Smals AGH, Trijbels FJM, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;313:709–715.PubMedGoogle Scholar
  72. 72.
    Easton JD, Sherman JD, Sherman DG. Cervical manipulation and stroke. Stroke. 1977;8:594–597.PubMedGoogle Scholar
  73. 73.
    Simon RR Neurosyphilis. Arch Neurol. 1985;42: 606–613.PubMedGoogle Scholar
  74. 74.
    Engstrom J. Reported by Goldsmith MR Neurologists study abnormal CSF, stroke associated with AIDS. JAMA. 1988;259:2957.Google Scholar
  75. 75.
    Snider WD, Simpson DM, Nielsen S, et al. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983;14:403–418.PubMedGoogle Scholar
  76. 76.
    Levy RM. Central nervous system disorders in AIDS. In: Levy JA, ed. AIDS: Pathogenesis and Treatment. New York, NY: Marcel Dekker Inc., 1988; pp 371–401.Google Scholar
  77. 77.
    Hillbom M, Kaste M, Rasi V. Can ethanol intoxication affect hemocoagulation with increased risk of infarction in young adults? Neurology. 1983;33: 381–384.PubMedGoogle Scholar
  78. 78.
    Caplan LR, Hier DB, Banks G. Stroke and drug abuse. Stroke. 1982;13:869–872.PubMedGoogle Scholar
  79. 79.
    Klonoff DC, Andrews BT, Obana WG. Stroke associated with cocaine use. Arch Neurol. 1989; 46:989–993.PubMedGoogle Scholar
  80. 80.
    Mangiardi JR, Daras M, Geller ME, et al. Cocaine-related intracranial hemorrhage. Report of nine cases and review. Acta Neurol Scan. 1988;77:177–180.Google Scholar
  81. 81.
    Diaz JF, Hachinski VC, Pederson L, et al. Aggregation of multiple risk factors for stroke in siblings of patients with brain infarction and transient ischemic attacks. Stroke. 1986;17:1240–1242.Google Scholar
  82. 82.
    Kagan A, Harris BR, Winkelstein W Jr, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis. 1974; 27:345–364.PubMedGoogle Scholar
  83. 83.
    Kagan A, Popper JS, Rhoads GG. Factors related to stroke incidence in Hawaiian Japanese men: the Honolulu heart study. Stroke. 1980;11:14–21.PubMedGoogle Scholar
  84. 84.
    Hennerici M, Hulsbomer HB, Hefter H, Lammerts D, Rautenberg W. Natural history of asymptomatic extracranial arterial disease. Brain. 1987; 110:777–791.PubMedGoogle Scholar
  85. 85.
    Wolf PA, Kannel WB, Sorlie P, et al. Asymptomatic carotid bruit and risk of stroke: the Framing-ham study. JAMA. 1981;245:1442–1445.PubMedGoogle Scholar
  86. 86.
    Yatsu FM, Fields WS. Asymptomatic carotid bruit: stenosis or ulceration, a conservative approach. Arch Neurol. 1985;42:383–385.PubMedGoogle Scholar
  87. 87.
    Dyken ML, Pokras R. The performance of endar-terectomy for disease of the extracranial arteries of the head. Stroke. 1984;15:948–950.PubMedGoogle Scholar
  88. 88.
    Hennerici M, Rautenberg W, Mohr S. Stroke risk from symptomless extracranial arterial disease. Lancet. 1982;2:1180–1183.PubMedGoogle Scholar
  89. 89.
    Chambers BR, Norris JW Outcome in patients with asymptomatic neck bruits. TV Engl J Med. 1986;315:860–865.Google Scholar
  90. 90.
    Chambers BR, Norris JW. The case against surgery for asymptomatic carotid stenosis. Stroke. 1984; 15:964–967.PubMedGoogle Scholar
  91. 91.
    Ford CS, Frye JL, Toole JF, et al. Asymptomatic carotid bruit and stenosis. A prospective follow-up study. Arch Neurol. 1986;43:219–222.PubMedGoogle Scholar
  92. 92.
    Veterans Administration Cooperative Study. Role of carotid endarterectomy in asymptomatic carotid stenosis. Stroke. 1986;17:534–539.Google Scholar
  93. 93.
    Wolf PA, DAgostino RB, Kannel WB, et al. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA. 1988;259:1025–1035.PubMedGoogle Scholar
  94. 94.
    Abbott RD, Yin Y, Reed DM, et al. Risk of stroke in male cigarette smokers. N Engl J Med. 1986; 315:717–720.PubMedGoogle Scholar
  95. 95.
    Colditz GA, Bonita R, Stampfer MJ, et al. Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med. 1988;318:937–941.PubMedGoogle Scholar
  96. 96.
    Pokras R, Dyken ML. Dramatic changes in the performance of endarterectomy for disease of the extracranial arteries of the head. Stroke. 1988; 19: 1289–1290.PubMedGoogle Scholar
  97. 97.
    Warlow CP Carotid endarterectomy: does it work? Stroke. 1984;15:1068–1076.PubMedGoogle Scholar
  98. 98.
    North American Symptomatic Carotid Endarterectomy Study Group. Carotid endarterectomy: three critical evaluations (editorial). Stroke. 1987; 18:987–989.Google Scholar
  99. 99.
    Genton E, Barnett HJM, Fields WS, et al. Report of the Joint Committee for Stroke Resources: 14. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy. Stroke. 1977;8:150–175.PubMedGoogle Scholar
  100. 100.
    Weksler BB, Lewin M. Anticoagulation in cerebral ischemia. Stroke. 1983;14:658–663.PubMedGoogle Scholar
  101. 101.
    Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978;299:53–59.Google Scholar
  102. 102.
    Bousser MG, Eschwege E, Haguenau M, et al. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke. 1983;14:5–14.PubMedGoogle Scholar
  103. 103.
    UK-TIA Study Group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Brit Med J. 1988;296:316–320.Google Scholar
  104. 104.
    Kurtzke JF. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study. Ann Neurol. 1979;5:597–599.PubMedGoogle Scholar
  105. 105.
    Armitage P. Controversy in the interpretation of clinical trials. Ann Neurol. 1979;5:601–602.PubMedGoogle Scholar
  106. 106.
    Candelise L, Landi G, Perrone P, et al. A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Stroke. 1982;13:175–179.PubMedGoogle Scholar
  107. 107.
    Dyken ML. Transient ischemic attacks and aspirin, stroke and death; negativities and Type II error (editorial). Stroke. 1983;14:2–4PubMedGoogle Scholar
  108. 108.
    The European Stroke Prevention Study Group. The European stroke prevention study (ESPS): principal end-points. Lancet. 1987;2:1351–1354.Google Scholar
  109. 109.
    The American-Canadian Cooperative Study Group. Persantine-Aspirin trial in cerebral ischemia: 2. Endpoint results. Stroke. 1985;16:406–415.Google Scholar
  110. 110.
    Swedish Cooperative Study Group. High-dose acetylsalicylic acid after cerebral infarction. Stroke. 1987;18:325–334.Google Scholar
  111. 111.
    Gent M, Blakely JA, Easton JD, et al. The Canadian-American Ticlopidine Study (CATS) in thromboembolic stroke: design, organization and baseline results. Stroke. 1988;19:1203–1210.PubMedGoogle Scholar
  112. 112.
    Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;25:382–390.PubMedGoogle Scholar
  113. 113.
    Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med. 1976;295:369–425.PubMedGoogle Scholar
  114. 114.
    Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34–47.PubMedGoogle Scholar
  115. 115.
    Javid H, Ostermiller WE, Hengesh JW, et al. Natural history of carotid bifurcation atheroma. Surgery. 1970;67:80–86.PubMedGoogle Scholar
  116. 116.
    Hennerici M, Rautenberg W, Trockel U, et al. Spontaneous progression and regression of small carotid atheroma. Lancet. 1985;1:1415–1419.PubMedGoogle Scholar
  117. 117.
    Roederer GO, Langlois YE, Jager KA, et al. The natural history of carotid arterial disease in asymptomatic patients with cervical bruits. Stroke. 1984; 15:605–613.PubMedGoogle Scholar
  118. 118.
    Malinow MR. Experimental models of atherosclerosis regression. Atherosclerosis. 1983;48:105–118.PubMedGoogle Scholar
  119. 119.
    Imparato AM, Riles TS, Mintzer R, et al. The importance of hemorrhage in the relationship between gross morphologic characteristics and cerebral symptoms in 376 carotid artery plaques. Ann Surg. 1983;197:195–203.PubMedGoogle Scholar
  120. 120.
    Fisher M, Levine PH, Weiner BH. The potential clinical benefits of fish oil consumption. Arch Intern Med. 1986;146:2322–2323.PubMedGoogle Scholar
  121. 121.
    Weiner BH, Ockene IS, Levine PH, et al. Inhibition of atherosclerosis by cod liver oil in a hyperlipidemic swine model. N Engl J Med. 1986;315:841–846.PubMedGoogle Scholar
  122. 122.
    Brattstrom LE, Herdebo JE, Hultberg BL. Moderate homocysteiremia—a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke. 1984;15:1012–1016.PubMedGoogle Scholar
  123. 123.
    Steering Committee of the Physicians’ Health Study Research Group. Preliminary report: findings from the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med. 1988;318: 262–264.Google Scholar
  124. 124.
    Hobson RW, Towne J. Carotid endarterectomy for asymptomatic carotid stenosis. Stroke. 1989; 20:575–576.PubMedGoogle Scholar
  125. 125.
    Hasso AN, Bird CR. Percutaneous transluminal angioplasty of carotid and vertebral arteries. In: Jang GC, ed. Angioplasty. New York, NY: McGraw-Hill Book Co., 1986: pp 104–115.Google Scholar
  126. 126.
    Yeng Y, Hashizume M, Arbutina D, et al. Argon laser angioplasty with a laser probe. J Vasc Surg. 1987;6:60–65.Google Scholar
  127. 127.
    La Muraglia GM, Mathews-Roth MM, Parrish JA, et al. Enhancing the carotenoid content of atherosclerotic plaque: implications for laser therapy. J Vasc Surg. 1989;9:563–567.Google Scholar
  128. 128.
    Kuller LH. Incidence rates of stroke in the eighties: the end of the decline in stroke (editorial). Stroke. 1989;20:841–843.PubMedGoogle Scholar
  129. 129.
    Wilkinson WE, Heyman A, Pfeffer RI, et al. A questionnaire for TIA symptoms: a predictor of subsequent stroke. In: Reivich M, Hurtig HI, eds. Cerebrovascular Diseases. New York, NY: Raven Press; 1983.Google Scholar
  130. 130.
    Colgan MP, Strode GR, Sommer JD, et al. Prevalence of asymptomatic carotid disease: Results of duplex scanning in 348 unselected volunteers. J Vasc Surg. 1988;8:674–678.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • John W. Norris
  • Vladimir C. Hachinski

There are no affiliations available

Personalised recommendations